€24 million investment in a new biorefinery at ZILS (Sines Industrial and Logistics Zone)
In recent years InKemia has developed a new biofuel (S-50) with characteristics similar to those of diesel and biodiesel. The S-50 has crude glycerin as one of its main raw materials. The S-50 has been totally developed within the European Union and thoroughly tested, both in laboratory environment and in engines.
The company selected Portugal – ZILS, adjacent to the harbor of Sines – to locate the first industrial facility in the world to produce and market the S-50. The total investment will amount to nearly 24 million euros, generating 23 FTE and inducing between 15 to 20 indirect jobs.
The project will positively impact Portuguese exports, since it is estimated that over 70% of its annual 30,000 metric tons production will be for the Spanish, Italian, German, Dutch and UK markets.
The industrial facility will take up about one hectare of Lot E, Zone 1 of ZILS, a petrochemical industrial site managed by aicep Portugal Global:
http://www.globalparques.pt/en/enzils/parks/zils-global-parques/summary/70
Categories
Investments
Chemical substances
Countries
Latest news
INEOS launches €250m investment supported by the French Government to secure the future of French industry at Lavera
The project marks the first phase of a long-term regeneration plan to reduce emissions, boost reliability, efficiency and competitiveness, with support of the French State.
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain